All Topics
All Topics
Technology
Technology
Design
Design
Programming
Programming
Science
Science
News
News
Gaming
Gaming
Entertainment
Entertainment
Business
Business
Finance
Finance
Sports
Sports
Health
Health
Food
Food
Travel
Travel
Art
Art
Music
Music
Books
Books
Education
Education
Politics
Politics
Personal
Personal
No algorithm. No AI slop. No ads. Just RSS. Pro-human. Indie writers. Real journalism. Open web. Chronological. Hand toasted.

Study Challenges Decades-Old View That DNA Is Locked Away When Wrapped Around Nucleosomes

By

Send as Email Share

1mo ago· 6 min readenNews

Summary

A new study from Gladstone Institutes and the Arc Institute challenges the long-held belief that DNA wrapped around nucleosomes is locked away and inaccessible. The prevailing view held that only unwrapped DNA could be active, but this research reveals that DNA isn't as tightly sealed as previously thought, with implications for understanding how subtle shifts in gene activity contribute to cancer, aging, and other complex diseases.

Key quotes

· 3 pulled
For decades, the prevailing view held that DNA is coiled so tightly around a nucleosome that it's basically locked away and the cell can't access it.
Scientists believed only unwrapped DNA could be active.
Now, a study from Gladstone Institutes and the Arc Institute challenges that black-and-white view.
Snippet from the RSS feed
A new study upends long-held view about how DNA is stored, explaining how subtle shifts in gene activity contribute to cancer, aging, and other complex diseases.

You might also wanna read

Exploring the science behind quantum effects in healthcare: separating research from pseudoscience

The article explores the intersection of quantum physics and healthcare, distinguishing between pseudoscientific "quantum therapies" and leg

newscientist.com·1h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·1h ago

Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer trial

A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug

chicagotribune.com·1h ago

Experimental daraxonrasib pill extends survival for advanced pancreatic cancer patients, study finds

An experimental pill called daraxonrasib has shown promise in helping patients with advanced pancreatic cancer live longer. The drug blocks

bit.ly·4h ago

Woman develops whiplike rash on back after eating shiitake mushrooms

A woman developed bright-red, whiplike rashes on her back after eating shiitake mushrooms, a condition known as shiitake dermatitis. The cas

livescience.com·5h ago

Molecular glue approach doubles survival time for pancreatic cancer patients in breakthrough trial

Chemical biologist Gregory Verdine developed a novel approach to fighting cancer by using "molecular glues" to bind disease-causing proteins

pasadenastarnews.com·7h ago